|
Ultrasound First, Not CT, For Diagnosing Suspected Acute Appendicitis
192 hours ago
Source: Medical News Today
Color Doppler ultrasound, not CT, should be the first imaging examination for adult patients with suspected acute appendicitis, a new study emphasizes.The study of 420 medical records found that sonography correctly denied acute appendicitis in 303 of 312 adult patients, meaning it had a 97% specificity rate, said Diana Gaitini, MD, of Rambam Health Care Campus in Haifa, Israel. ... more
|
|
|
BiPar Sciences Expands Phase 2 Clinical Trials Of BSI-201, A Novel DNA Repair Inhibitor, In Ovarian Cancer
192 hours ago
Source: Medical News Today
BiPar Sciences, Inc. announced the expansion of Phase 2 clinical trial programs for its lead product, BSI-201, in ovarian cancer. This is the third major clinical trial of BSI-201 that BiPar has launched in the past 6 months, expanding on on going trials in breast and brain cancer. ... more
|
|
|
Carotid Bruit Linked To Cardiovascular Problems
192 hours ago
Source: Medical News Today
People who have a carotid bruit are at a significantly greater risk ofcardiovascular death and heart attack, according to an articlepublished in The Lancet. A carotid bruitis a sound that blood makes when it passes over an obstruction in thecarotid artery, the main passageway for supplying blood to the head andneck. ... more
|
|
|
Free Antiretroviral Treatment In Malawi Proving Effective
192 hours ago
Source: Medical News Today
According to an article published in The Lancet,adult mortality of HIV patients in Malawi has been significantlyreduced after the introduction of free antiretroviral therapy (ART).The effect, say researchers, is large enough to detect at thepopulation level.Malawi, a country of about 13 million people located in southeasternAfrica, sees some 80,000 deaths from AIDS each year. ... more
|
|
|
Molecules In Plants May Have Beneficial Effect On Alzheimer's Disease
192 hours ago
Source: Medical News Today
A set of molecules found in certain plants appears to have a beneficial effect in brain tissue associated with Alzheimer's disease, according to a new study conducted in mice. The study was led by researchers at the University of South Florida and Cedars-Sinai Medical Center. An article in the Journal of Cellular and Molecular Medicine is available online.Terrence Town, Ph.D. ... more
|
|
|
New Lacosamide Data Provides Evidence For Long-Term Efficacy In Diabetic Neuropathic Pain
192 hours ago
Source: Medical News Today
Patients treated with lacosamide demonstrated sustained pain relief from diabetic neuropathic pain (DNP), compared to placebo-treated patients, according to data presented at the 27th annual meeting of the American Pain Society (APS) in Tampa, Fla. ... more
|
|
|
Obesity Linked To Increased Risk For Dementia
192 hours ago
Source: Medical News Today
Obesity may increase adults' risk for having dementia, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Their analysis of published obesity and dementia prospective follow-up studies over the past two decades shows a consistent relationship between the two diseases. ... more
|
|
|
Too Much Or Too Little Weight Gain Poses Risks To Pregnant Mothers, Babies
192 hours ago
Source: Medical News Today
Women who gain more or less than recommended amounts of weight during pregnancy are likely to increase the risk of problems for both themselves and their child, according to a new report by the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.The report, which was supported by the U.S. ... more
|
|
|
Vion Pharmaceuticals Announces Initiation Of Clinical Trial Of Cloretazine(R) (VNP40101M) In Combination With Cytarabine
192 hours ago
Source: Medical News Today
VION PHARMACEUTICALS, INC. (Nasdaq: VION) announced the start of an investigator-sponsored Phase I/II clinical trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in combination with cytarabine in elderly patients with previously untreated acute myelogenous leukemia (AML) and high-risk myelodysplastic syndromes (MDS). ... more
|
|
|
Bayer And Regeneron Dose First Patient In Second Phase 3 Study For VEGF Trap-Eye In Wet Age-Related Macular Degeneration
192 hours ago
Source: Medical News Today
Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that the first patient has been dosed in the VIEW 2 trial, a second Phase 3 clinical study in a development program evaluating VEGF Trap-Eye for the treatment of the neovascular form of Age-related Macular Degeneration (wet AMD), a leading cause of blindness in adults. ... more
|
Next